Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Diplomat Pharmacy, Inc. (DPLO)

NEW YORK, Nov. 11, 2016 -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Diplomat Pharmacy, Inc. (“Diplomat” or the “Company”) (NYSE:DPLO) in the United States District Court for the Eastern District of Michigan on behalf of purchasers of common stock of Diplomat between October 9, 2014 through November 2, 2016 (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the Securities Exchange Act of 1934.

According to the Complaint, Defendants issued false and misleading statements to investors and/or failed to disclose that: (i) the Company lacked adequate internal controls over its financial reporting; (ii) as a result the Company could not adequately calculate DIR fees; (iii) the Company’s hepatitis C segment was not performing as previously disclosed to investors; (iv) and therefore, the Company had overstated its full-year 2016 guidance; and (v) that, as a result of the foregoing, Defendants’ statements about Diplomat’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.  When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than January 9, 2017.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  If you wish to join the litigation, or to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at [email protected] or [email protected].

Please visit our website at http://www.gme-law.com for more information about the firm.